Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Methanocorpusculum labreanum 6,7-dimethyl-8-ribityllumazine synthase (ribH) CSB-YP384797MNT
CSB-EP384797MNT
CSB-BP384797MNT
CSB-MP384797MNT
CSB-EP384797MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum Digeranylgeranylglycerophospholipid reductase (Mlab_0431) CSB-YP384798MNT
CSB-EP384798MNT
CSB-BP384798MNT
CSB-MP384798MNT
CSB-EP384798MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum 1- (5-phosphoribosyl)-5-[ (5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase CSB-YP384799MNT
CSB-EP384799MNT
CSB-BP384799MNT
CSB-MP384799MNT
CSB-EP384799MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum Glutamyl-tRNA reductase (hemA) CSB-YP384800MNT
CSB-EP384800MNT
CSB-BP384800MNT
CSB-MP384800MNT
CSB-EP384800MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum Elongation factor 1-beta (ef1b) CSB-YP384801MNT
CSB-EP384801MNT
CSB-BP384801MNT
CSB-MP384801MNT
CSB-EP384801MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum Probable bifunctional tRNA threonylcarbamoyladenosine biosynthesis protein (Mlab_0653), partial CSB-YP384802MNT
CSB-EP384802MNT
CSB-BP384802MNT
CSB-MP384802MNT
CSB-EP384802MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum UPF0218 protein Mlab_0656 (Mlab_0656) CSB-YP384803MNT
CSB-EP384803MNT
CSB-BP384803MNT
CSB-MP384803MNT
CSB-EP384803MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum Serine--tRNA ligase (serS) CSB-YP384804MNT
CSB-EP384804MNT
CSB-BP384804MNT
CSB-MP384804MNT
CSB-EP384804MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum Aspartate carbamoyltransferase (pyrB) CSB-YP384805MNT
CSB-EP384805MNT
CSB-BP384805MNT
CSB-MP384805MNT
CSB-EP384805MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum Digeranylgeranylglyceryl phosphate synthase (Mlab_0795), partial CSB-YP384806MNT
CSB-EP384806MNT
CSB-BP384806MNT
CSB-MP384806MNT
CSB-EP384806MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum Formate--tetrahydrofolate ligase (fhs), partial CSB-YP384807MNT
CSB-EP384807MNT
CSB-BP384807MNT
CSB-MP384807MNT
CSB-EP384807MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum Proteasome subunit beta (psmB) CSB-YP384808MNT
CSB-EP384808MNT
CSB-BP384808MNT
CSB-MP384808MNT
CSB-EP384808MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum Putative fused cobalt transport protein CbiMQ (cbiMQ), partial CSB-YP384809MNT
CSB-EP384809MNT
CSB-BP384809MNT
CSB-MP384809MNT
CSB-EP384809MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum DNA mismatch repair protein mutL (mutL), partial CSB-YP384810MNT
CSB-EP384810MNT
CSB-BP384810MNT
CSB-MP384810MNT
CSB-EP384810MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum V-type ATP synthase beta chain (atpB) CSB-YP384811MNT
CSB-EP384811MNT
CSB-BP384811MNT
CSB-MP384811MNT
CSB-EP384811MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum DNA-directed RNA polymerase subunit K (rpoK) CSB-YP384812MNT
CSB-EP384812MNT
CSB-BP384812MNT
CSB-MP384812MNT
CSB-EP384812MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum 30S ribosomal protein S13P (rps13p) CSB-YP384813MNT
CSB-EP384813MNT
CSB-BP384813MNT
CSB-MP384813MNT
CSB-EP384813MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum UPF0179 protein Mlab_1307 (Mlab_1307) CSB-YP384814MNT
CSB-EP384814MNT
CSB-BP384814MNT
CSB-MP384814MNT
CSB-EP384814MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum Probable thymidylate kinase (tmk) CSB-YP384815MNT
CSB-EP384815MNT
CSB-BP384815MNT
CSB-MP384815MNT
CSB-EP384815MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocorpusculum labreanum 2-phospho-L-lactate guanylyltransferase (cofC) CSB-YP384816MNT
CSB-EP384816MNT
CSB-BP384816MNT
CSB-MP384816MNT
CSB-EP384816MNT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>